Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Nemestran®:Sanofi-Aventis (Suisse) SA
Vollst. FachinformationDDDDrucken 
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
G03XA02 - GestrinoneATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
G03 - Sex Hormones and Modulators Of The Genital System

Other hormones, see H - Systemic hormonal preparations, excl. sex hormones and insulins.
Sex hormones used only in the treatment of neoplastic diseases (often selected strengths) are classified in L - Antineoplastic and immunomodulating agents.

The DDDs of many of the hormone preparations may vary considerably with the route of administration due to substantial differences in bioavailability. The DDDs of depot preparations are calculated as the dose divided by the dosing interval.

G03X - Other Sex Hormones and Modulators Of The Genital System

This group comprises drugs modifying the genital functions, which cannot be classified in the preceding groups.
Tibolone is classified in G03DC.

G03XA - Antigonadotropins and Similar Agents

The DDDs of danazol and gestrinone are based on the treatment of endometriosis.

G03XA02 - Gestrinone
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home